Natural killer cells: a promising immunotherapy for cancer
J Chu, F Gao, M Yan, S Zhao, Z Yan, B Shi… - Journal of translational …, 2022 - Springer
As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …
recently gained attention as an important type of innate immune regulatory cell. NK cells can …
Activating and inhibitory receptors of natural killer cells
HJ Pegram, DM Andrews, MJ Smyth… - Immunology and cell …, 2011 - Wiley Online Library
Natural killer (NK) cells are potent immune effector cells that can respond to infection and
cancer, as well as allowing maternal adaptation to pregnancy. In response to malignant …
cancer, as well as allowing maternal adaptation to pregnancy. In response to malignant …
CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
V Konduri, D Oyewole-Said, J Vazquez-Perez… - Frontiers in …, 2021 - frontiersin.org
NK1. 1 and its human homolog CD161 are expressed on NK cells, subsets of CD4+ and
CD8+ T cells, and NKT cells. While the expression of NK1. 1 is thought to be inhibitory to NK …
CD8+ T cells, and NKT cells. While the expression of NK1. 1 is thought to be inhibitory to NK …
[HTML][HTML] Ceramide-enriched membrane domains—structure and function
Membrane lipids seem to be organized and not randomly distributed in the cell membrane.
In particular, sphingolipids seem to interact with cholesterol in the outer leaflet of the cell …
In particular, sphingolipids seem to interact with cholesterol in the outer leaflet of the cell …
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients
D Pieragostino, I Cicalini, P Lanuti, E Ercolino… - Scientific Reports, 2018 - nature.com
Abstract Multiple Sclerosis (MuS) is a complex multifactorial neuropathology, resulting in
heterogeneous clinical presentation. A very active MuS research field concerns the …
heterogeneous clinical presentation. A very active MuS research field concerns the …
[HTML][HTML] Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase
H Xiang, S Jin, F Tan, Y Xu, Y Lu, T Wu - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Sphingomyelin (SM) can be converted into ceramide (Cer) by neutral sphingomyelinase
(NSM) and acid sphingomyelinase (ASM). Cer is a second messenger of lipids and can …
(NSM) and acid sphingomyelinase (ASM). Cer is a second messenger of lipids and can …
LLT1-CD161 interaction in cancer: promises and challenges
The success of immune checkpoint therapy in cancer has changed our way of thinking,
promoting the design of future cancer treatments that places the immune system at the …
promoting the design of future cancer treatments that places the immune system at the …
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases
Sphingolipids are a class of bioactive lipids, which are key modulators of an increasing
number of physiologic and pathophysiologic processes that include cell cycle, apoptosis …
number of physiologic and pathophysiologic processes that include cell cycle, apoptosis …
[HTML][HTML] Two distinct molecular faces of preeclampsia revealed by single-cell transcriptomics
I Admati, N Skarbianskis, H Hochgerner, O Ophir… - Med, 2023 - cell.com
Introduction Preeclampsia is a multisystemic, pregnancy-specific disorder united by new-
onset hypertension but with considerable variation in clinical manifestation, onset, and …
onset hypertension but with considerable variation in clinical manifestation, onset, and …
Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses
C Germain, A Meier, T Jensen, P Knapnougel… - Journal of Biological …, 2011 - ASBMB
CD161 is a C-type lectin-like receptor expressed on human natural killer (NK) cells and
subsets of T cells. CD161 has been described as an inhibitory receptor that regulates NK …
subsets of T cells. CD161 has been described as an inhibitory receptor that regulates NK …